The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Statin therapy and autoimmune disease: from protein prenylation to immunomodulation
Open accessAbstract
Statins have been prescribed extensively for their cholesterol-lowering properties and efficacy in cardiovascular disease. However, compelling evidence now exists that statins also have extensive immunomodulatory properties that operate independently of lipid lowering. Consequently, much attention has been directed towards their potential as therapeutic agents for the treatment of autoimmune disease. Modulation of post-translational protein prenylation seems to be a key mechanism by which statins alter immune function. In this Review, the effect of statin therapy on immune function, and how this relates to the pathogenesis of autoimmune disease, is reviewed alongside current opinion of what the key biological targets of statins are.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide: an endogenous modulator of leukocyte adhesion.
Kubes, P., Suzuki, M., & Granger, D. N. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4651 · Cited by 3,029
The many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523
Takai, Y., Sasaki, T., & Matozaki, T. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.1.153 · Cited by 2,475
Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors
Laufs, U., La Fata, V., Plutzky, J., & Liao, J. K. (1998) · Circulation · doi:10.1161/01.cir.97.12.1129 · Cited by 1,839
De Caterina, R., Libby, P., Peng, H. B., Thannickal, V. J., Rajavashisth, T. B., Gimbrone, M. A., Shin, W. S., & Liao, J. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118074 · Cited by 1,782
PROTEIN PRENYLATION: Molecular Mechanisms and Functional Consequences
Zhang, F. L., & Casey, P. J. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.001325 · Cited by 1,743
Collins, T., Read, M. A., Neish, A. S., Whitley, M. Z., Thanos, D., & Maniatis, T. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.10.7542214 · Cited by 1,718
The lineage decisions of helper T cells
Murphy, K. M., & Reiner, S. L. (2002) · Nature Reviews Immunology · doi:10.1038/nri954 · Cited by 1,674
Kureishi, Y., Luo, Z., Shiojima, I., Bialik, A., Fulton, D., Lefer, D. J., Sessa, W. C., & Walsh, K. (2000) · Nature Medicine · doi:10.1038/79510 · Cited by 1,439
Statins as a newly recognized type of immunomodulator.
Kwak, B., Mulhaupt, F., Myit, S., & Mach, F. (2000) · Nature Medicine · doi:10.1038/82219 · Cited by 1,383
ROLE OF ABERRANT HLA-DR EXPRESSION AND ANTIGEN PRESENTATION IN INDUCTION OF ENDOCRINE AUTOIMMUNITY
Bottazzo, G., Hanafusa, T., Pujol-Borrell, R., & Feldmann, M. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90629-3 · Cited by 1,256
Effect of Statins on Risk of Coronary Disease: A Meta-analysis of Randomized Controlled Trials
LaRosa, J. C., He, J., & Vupputuri, S. (1999) · JAMA · doi:10.1001/jama.282.24.2340 · Cited by 1,246
Current Perspectives on Statins
Maron, D. J., Fazio, S., & Linton, M. F. (2000) · Circulation · doi:10.1161/01.cir.101.2.207 · Cited by 1,213
Youssef, S., Stüve, O., Patarroyo, J. C., Ruiz, P. J., Radosevich, J. L., Hur, E. M., Bravo, M., Mitchell, D. J., Sobel, R. A., Steinman, L., et al. (2002) · Nature · doi:10.1038/nature01158 · Cited by 1,097
Self-citationWeitz-Schmidt, G., Welzenbach, K., Brinkmann, V., Kamata, T., Kallen, J., Bruns, C., Cottens, S., Takada, Y., & Hommel, U. (2001) · Nature Medicine · doi:10.1038/89058 · Cited by 1,041
Post-transcriptional Regulation of Endothelial Nitric Oxide Synthase mRNA Stability by Rho GTPase
Laufs, U., & Liao, J. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.24266 · Cited by 1,035 · cited 1×
“It has been proposed that inhibition of RHO prenylation by statins is a key factor in upregulating eNOS expression and stabilit”
BackgroundThe T Lymphocyte In Experimental Allergic Encephalomyelitis
Zamvil, S. (1990) · Annual Review of Immunology · doi:10.1146/annurev.immunol.8.1.579 · Cited by 1,009
Self-citationEndres, M., Laufs, U., Huang, Z., Nakamura, T., Huang, P., Moskowitz, M. A., & Liao, J. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8880 · Cited by 966
McCarey, D. W., McInnes, I. B., Madhok, R., Hampson, R., Scherbakova, O., Ford, I., Capell, H. A., & Sattar, N. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16449-0 · Cited by 818
Hernández-Perera, O., Pérez-Sala, D., Navarro-Antolín, J., Sánchez-Pascuala, R., Hernández, G., Díaz, C., & Lamas, S. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1500 · Cited by 763
Statins do more than just lower cholesterol
Vaughan, C. J., Murphy, M. B., & Buckley, B. M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)05190-2 · Cited by 698
Pahan, K., Sheikh, F. G., Namboodiri, A. M., & Singh, I. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119812 · Cited by 571
Wagner, A. H., Köhler, T., Rückschloss, U., Just, I., & Hecker, M. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.1.61 · Cited by 516
HMG-CoA Reductase Inhibitors Reduce MMP-9 Secretion by Macrophages
Bellosta, S., Via, D., Canavesi, M., Pfister, P., Fumagalli, R., Paoletti, R., & Bernini, F. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.11.1671 · Cited by 512
Oral simvastatin treatment in relapsing-remitting multiple sclerosis
Vollmer, T., Key, L., Durkalski, V., Tyor, W., Corboy, J., Markovic-Plese, S., Preiningerova, J., Rizzo, M., & Singh, I. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16205-3 · Cited by 469
A novel anti-inflammatory role for simvastatin in inflammatory arthritis.
Leung, B. P., Sattar, N., Crilly, A., Prach, M., McCarey, D. W., Payne, H., Madhok, R., Campbell, C., Gracie, J. A., Liew, F. Y., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1524 · Cited by 434
Weber, C., Erl, W., Weber, K. S. C., & Weber, P. C. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00324-0 · Cited by 411
Rho, Rac and Cdc42 regulate actin organization and cell adhesion in macrophages
Allen, W. E., Jones, G. E., Pollard, J. W., & Ridley, A. J. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.6.707 · Cited by 409
Is atherosclerosis an immunologically mediated disease?
Wick, G., Schett, G., Amberger, A., Kleindienst, R., & Xu, Q. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80067-0 · Cited by 398
Stamatovic, S. M., Keep, R. F., Kunkel, S. L., & Andjelkovic, A. V. (2003) · Journal of Cell Science · doi:10.1242/jcs.00755 · Cited by 381 · cited 1×
“Interestingly, expression of the chemokine receptor CCR2 (a receptor for CCL2) by brain endothelial cells initiates junctional opening in a RHO-dependent manne”
BackgroundShimonaka, M., Katagiri, K., Nakayama, T., Fujita, N., Tsuruo, T., Yoshie, O., & Kinashi, T. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200301133 · Cited by 359
Isoprenoids as mediators of the biological effects of statins
Liao, J. K. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216421 · Cited by 352
Bath, P. M., Hassall, D. G., Gladwin, A. M., Palmer, R. M., & Martin, J. F. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.2.254 · Cited by 325
Etienne-Manneville, S., Manneville, J.-B., Adamson, P., Wilbourn, B., Greenwood, J., & Couraud, P.-O. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3375 · Cited by 298
Self-citationInhibition of Monocyte Chemotactic Protein-1 Synthesis by Statins
Romano, M., Diomede, L., Sironi, M., Massimiliano, L., Sottocorno, M., Polentarutti, N., Guglielmotti, A., Albani, D., Bruno, A., Fruscella, P., et al. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780115 · Cited by 298
Adamson, P., Etienne, S., Couraud, P.-O., Calder, V., & Greenwood, J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.5.2964 · Cited by 296
Self-citationAktas, O., Waiczies, S., Smorodchenko, A., Dörr, J., Seeger, B., Prozorovski, T., Sallach, S., Endres, M., Brocke, S., Nitsch, R., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021425 · Cited by 282
van Wetering, S., van Buul, J. D., Quik, S., Mul, F. P. J., Anthony, E. C., Klooster, J.-P. T., Collard, J. G., & Hordijk, P. L. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.9.1837 · Cited by 278
Braga, V. M. M., Del Maschio, A., Machesky, L., & Dejana, E. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.1.9 · Cited by 257
Spiecker, M., Peng, H.-B., & Liao, J. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30969 · Cited by 255
ICAM-1 Signaling Pathways Associated with Rho Activation in Microvascular Brain Endothelial Cells
Etienne, S., Adamson, P., Greenwood, J., Strosberg, A. D., Cazaubon, S., & Couraud, P.-O. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.10.5755 · Cited by 248
Self-citationHo, I.-C., & Glimcher, L. H. (2002) · Cell · doi:10.1016/s0092-8674(02)00705-5 · Cited by 234
Steinman, L., Rosenbaum, J. T., Sriram, S., & McDevitt, H. O. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.7111 · Cited by 227
Self-citationGreenwood, J., Walters, C. E., Pryce, G., Kanuga, N., Bemud, E., Baker, D., & Adamson, P. (2003) · The FASEB Journal · doi:10.1096/fj.02-1014fje · Cited by 227
Self-citationStatins as immunomodulators: Comparison with interferon-β1b in MS
Neuhaus, O., Strasser-Fuchs, S., Fazekas, F., Kieseier, B. C., Niederwieser, G., Hartung, H. P., & Archelos, J. J. (2002) · Neurology · doi:10.1212/wnl.59.7.990 · Cited by 215
Dunn, S. E., Youssef, S., Goldstein, M. J., Prod'homme, T., Weber, M. S., Zamvil, S. S., & Steinman, L. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051129 · Cited by 211
Self-citationFurther Checkpoints in Th1 Development
Robinson, D. S., & O'Garra, A. (2002) · Immunity · doi:10.1016/s1074-7613(02)00331-x · Cited by 204
Yoshida, M., Sawada, T., Ishii, H., Gerszten, R. E., Rosenzweig, A., Gimbrone, M. A., Yasukochi, Y., & Numano, F. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0701.092143 · Cited by 187
VCAM-1-mediated Rac signaling controls endothelial cell-cell contacts and leukocyte transmigration
van Wetering, S., van den Berk, N., van Buul, J. D., Mul, F. P. J., Lommerse, I., Mous, R., Klooster, J.-P. T., Zwaginga, J.-J., & Hordijk, P. L. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00048.2003 · Cited by 185
Veillard, N. R., Braunersreuther, V., Arnaud, C., Burger, F., Pelli, G., Steffens, S., & Mach, F. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.10.015 · Cited by 175
Frenkel, J., Rijkers, G. T., Mandey, S. H. L., Buurman, S. W. M., Houten, S. M., Wanders, R. J. A., Waterham, H. R., & Kuis, W. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10550 · Cited by 171
Morikawa, S., Takabe, W., Mataki, C., Kanke, T., Itoh, T., Wada, Y., Izumi, A., Saito, Y., Hamakubo, T., & Kodama, T. (2002) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.9.178 · Cited by 167
Anti-inflammatory and analgesic effects of atorvastatin in a rat model of adjuvant-induced arthritis
Barsante, M. M., Roffê, E., Yokoro, C. M., Tafuri, W. L., Souza, D. G., Pinho, V., Castro, M. S. D. A., & Teixeira, M. M. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.05.005 · Cited by 164
Amelioration of experimental allergic encephalomyelitis in Lewis rats by lovastatin
Stanislaus, R., Pahan, K., Singh, A. K., & Singh, I. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00414-0 · Cited by 164
Schönbeck, U., Gerdes, N., Varo, N., Reynolds, R. S., Horton, D. B., Bavendiek, U., Robbie, L., Ganz, P., Kinlay, S., & Libby, P. (2002) · Circulation · doi:10.1161/01.cir.0000043029.52803.7b · Cited by 162
Sriram, S., & Steinman, L. (1983) · The Journal of experimental medicine · doi:10.1084/jem.158.4.1362 · Cited by 160
Self-citationNath, N., Giri, S., Prasad, R., Singh, A. K., & Singh, I. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.1273 · Cited by 158
Ghittoni, R., Patrussi, L., Pirozzi, K., Pellegrini, M., Lazzerini, P. E., Capecchi, P. L., Pasini, F. L., & Baldari, C. T. (2005) · The FASEB Journal · doi:10.1096/fj.04-2702fje · Cited by 154 · cited 1×
“By contrast, it has been shown that in Jurkat T cells lipid rafts were only disrupted when statins were applied in the absence of seru”
ResultWong, B., Lumma, W. C., Smith, A. M., Sisko, J. T., Wright, S. D., & Cai, T. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.6.959 · Cited by 154
Mason, R. P., Walter, M. F., Day, C. A., & Jacob, R. F. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.06.008 · Cited by 153
Sadeghi, M. M., Collinge, M., Pardi, R., & Bender, J. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2712 · Cited by 146
Rezaie-Majd, A., Prager, G. W., Bucek, R. A., Schernthaner, G.-H., Maca, T., Kress, H. G., Valent, P., Binder, B. R., Minar, E., & Baghestanian, M. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000059384.34874.f0 · Cited by 146
Chakrabarti, R., & Engleman, E. G. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98884-8 · Cited by 145
Turner, N. A., O'Regan, D. J., Ball, S. G., & Porter, K. E. (2005) · The FASEB Journal · doi:10.1096/fj.04-2852fje · Cited by 143
Zamvil, S. S., Nelson, P., Mitchell, D. J., Knobler, R. L., Fritz, R. B., & Steinman, L. (1985) · The Journal of Experimental Medicine · doi:10.1084/jem.162.6.2107 · Cited by 141
Self-citationYılmaz, A., Reiss, C., Tantawi, O., Weng, A., Stumpf, C., Raaz, D., Ludwig, J., Berger, T. G., Steinkasserer, A., Daniel, W. G., et al. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.10.002 · Cited by 141
Stanislaus, R., Singh, A. K., & Singh, I. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1207 · Cited by 140
Lymphocyte migration into the central nervous system
Greenwood, J., Etienne‐Manneville, S., Adamson, P., & Couraud, P. (2002) · Vascular Pharmacology · doi:10.1016/s1537-1891(02)00199-4 · Cited by 138
Self-citationAtorvastatin activates PPAR-γ and attenuates the inflammatory response in human monocytes
Grip, O., Janciauskiene, S. M., & Lindgren, S. C. (2002) · Inflammation Research · doi:10.1007/bf02684000 · Cited by 123
Therapy with statins in patients with refractory rheumatic diseases: a preliminary study
Abud‐Mendoza, C., de la Fuente, H., Cuevas-Orta, E., Baranda, L., Cruz-Rizo, J., & González‐Amaro, R. (2003) · Lupus · doi:10.1191/0961203303lu429oa · Cited by 121
Nübel, T., Dippold, W. G., Kleinert, H., Kaina, B., & Fritz, G. (2003) · The FASEB Journal · doi:10.1096/fj.03-0261fje · Cited by 119
Lawman, S. H. A., Mauri, C., Jury, E. C., Cook, H. T., & Ehrenstein, M. R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7641 · Cited by 118
Walters, C. E., Pryce, G., Hankey, D. J. R., Sebti, S. M., Hamilton, A. D., Baker, D., Greenwood, J., & Adamson, P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.8.4087 · Cited by 115
Self-citationWagner, A. H., Gebauer, M., Güldenzoph, B., & Hecker, M. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000037098.20829.31 · Cited by 109
New Evidence for Beneficial Effects of Statins Unrelated to Lipid Lowering
Palinski, W. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.1.3 · Cited by 108
Stüve, O. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25805 · Cited by 107
Cook‐Mills, J. M., Johnson, J. D., Deem, T. L., Ochi, A., Wang, L., & Zheng, Y. (2004) · Biochemical Journal · doi:10.1042/bj20030794 · Cited by 106
NITRIC OXIDE ATTENUATES ADHESION MOLECULE EXPRESSION IN HUMAN ENDOTHELIAL CELLS
Takahashi, M., Ikeda, U., Masuyama, J., Funayama, H., Kano, S., & Shimada, K. (1996) · Cytokine · doi:10.1006/cyto.1996.0109 · Cited by 97
Therapeutic potential of lovastatin in multiple sclerosis
Sena, A., Pedrosa, R., & Morais, M. G. (2003) · Journal of Neurology · doi:10.1007/s00415-003-1070-8 · Cited by 96
Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation
Houten, S. M., Frenkel, J., & Waterham, H. R. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-2296-4 · Cited by 96
Kuipers, H. F., Biesta, P. J., Groothuis, T. A., Neefjes, J., Mommaas, A. M., & van den Elsen, P. J. (2005) · Human Immunology · doi:10.1016/j.humimm.2005.04.004 · Cited by 89
Fournié, G. J., Cautain, B., Xystrakis, E., et al. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1840114.x · Cited by 85
Assessment of the efficacy of different statins in murine collagen‐induced arthritis
Palmer, G., Chobaz, V., Talabot‐Ayer, D., Taylor, S., So, A. K.-L., Gabay, C., & Busso, N. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20673 · Cited by 83
Turowski, P., Adamson, P., & Greenwood, J. (2005) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-004-1380-0 · Cited by 82
Self-citationDendritic cells: New roles for Cdc42 and Rac in antigen uptake?
Nobes, C. D., & Marsh, M. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00736-3 · Cited by 81
Sadeghi, M. M., Tiglio, A., Sadigh, K., Donnell, L. O., Collinge, M., Pardi, R., & Bender, J. R. (2001) · Transplantation · doi:10.1097/00007890-200105150-00014 · Cited by 74
Ganné, F., Vasse, M., Beaudeux, J., Peynet, J., François, A., Mishal, Z., Chartier, A., Tobelem, G., Vannier, J., Soria, J., et al. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614087 · Cited by 73
Paintlia, A. S., Paintlia, M. K., Singh, A. K., Stanislaus, R., Gilg, A. G., Barbosa, E., & Singh, I. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20130 · Cited by 73
Immunomodulation of experimental autoimmune encephalomyelitis in the Lewis rats by Lovastatin
Stanislaus, R., Gilg, A. G., Singh, A. K., & Singh, I. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00943-6 · Cited by 73
Suppression of Autoimmune Retinal Disease by Lovastatin Does Not Require Th2 Cytokine Induction
Gegg, M. E., Harry, R. A., Hankey, D. J. R., Zambarakji, H., Pryce, G., Baker, D., Adamson, P., Calder, V. L., & Greenwood, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.2327 · Cited by 71
Self-citationLiu, W., Li, W., Gao, C., & Sun, N. (2005) · Journal of Autoimmunity · doi:10.1016/j.jaut.2005.06.005 · Cited by 69
Zamvil, S. S., & Steinman, L. (2002) · Neurology · doi:10.1212/wnl.59.7.970 · Cited by 61
Self-citationArterial Inflammation and Atherosclerosis
Ludewig, B. (2002) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00166-9 · Cited by 57
Mach, F. (2002) · Transplant Immunology · doi:10.1016/s0966-3274(02)00030-8 · Cited by 54
Immunomodulation for treatment and prevention of atherosclerosis
Sherer, Y., & Shoenfeld, Y. (2002) · Autoimmunity Reviews · doi:10.1016/s1568-9972(01)00003-9 · Cited by 54
Azuma, R. W., SUZUKI, J., OGAWA, M., Futamatsu, H., Koga, N., Onai, Y., Kosuge, H., & ISOBE, M. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.09.014 · Cited by 54
Xenos, E. S., Stevens, S. L., Freeman, M. B., Cassada, D. C., & Goldman, M. H. (2005) · Annals of Vascular Surgery · doi:10.1007/s10016-005-0011-7 · Cited by 51
Prasad, R. C., Giri, S., Nath, N., Singh, I., & Singh, A. K. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03182.x · Cited by 50
Anti-inflammatory Properties of Statins
Steffens, S., & Mach, F. (2004) · Seminars in Vascular Medicine · doi:10.1055/s-2004-869599 · Cited by 49
Statins and autoimmune diseases
Gurevich, V. S., Shovman, O., Slutzky, L., Meroni, P. L., & Shoenfeld, Y. (2004) · Autoimmunity Reviews · doi:10.1016/j.autrev.2004.08.037 · Cited by 38
Kieseier, B. C., Archelos, J. J., & Hartung, H. (2004) · Archives of Neurology · doi:10.1001/archneur.61.6.929 · Cited by 37
The effects of atorvastatin in experimental autoimmune uveitis
Thomas, P. B. (2005) · British Journal of Ophthalmology · doi:10.1136/bjo.2004.050401 · Cited by 36
Zuckerbraun, B. S., Barbato, J. E., Hamilton, A. D., Sebti, S. M., & Tzeng, E. (2004) · Journal of Surgical Research · doi:10.1016/j.jss.2004.10.022 · Cited by 18
Sättler, M. B., Diem, R., Merkler, D., Demmer, I., Boger, I., Stadelmann, C., & Bähr, M. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.12.010 · Cited by 15
Cuthbert, J. A., & Lipsky, P. E. (1991) · PubMed · Cited by 7
Cited by
The immune response in atherosclerosis: a double-edged sword
Hansson, G. K., & Libby, P. (2006) · Nature Reviews Immunology · doi:10.1038/nri1882 · Cited by 2,182
Alternative macrophage activation and metabolism
Odegaard, J. I., & Chawla, A. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130138 · Cited by 640
Pleiotropic effects of statin therapy: molecular mechanisms and clinical results
Wang, C.-Y., Liu, P.-Y., & Liao, J. K. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.11.004 · Cited by 593
Steinman, L., & Zamvil, S. S. (2006) · Annals of Neurology · doi:10.1002/ana.20913 · Cited by 479
Self-citationProgressive multiple sclerosis: from pathophysiology to therapeutic strategies
Faissner, S., Plemel, J. R., Gold, R., & Yong, V. W. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0035-2 · Cited by 459
Metadata
- Authors
- Greenwood, J., Steinman, L., & Zamvil, S. S.
- Venue
- Nature Reviews Immunology
- Published
- 2006-05
- Volume
- 6
- Issue
- 5
- Pages
- 358-370
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2072318687
- Cited by
- 683
- References
- 105
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.